Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review
Top Cited Papers
Open Access
- 4 July 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Orphanet Journal of Rare Diseases
- Vol. 12 (1), 1-15
- https://doi.org/10.1186/s13023-017-0671-8
Abstract
Spinal muscular atrophy linked to chromosome 5q (SMA) is a recessive, progressive, neuromuscular disorder caused by bi-allelic mutations in the SMN1 gene, resulting in motor neuron degeneration and variable presentation in relation to onset and severity. A prevalence of approximately 1–2 per 100,000 persons and incidence around 1 in 10,000 live births have been estimated with SMA type I accounting for around 60% of all cases. Since SMA is a relatively rare condition, studies of its prevalence and incidence are challenging. Most published studies are outdated and therefore rely on clinical rather than genetic diagnosis. Furthermore they are performed in small cohorts in small geographical regions and only study European populations. In addition, the heterogeneity of the condition can lead to delays and difficulties in diagnosing the condition, especially outside of specialist clinics, and contributes to the challenges in understanding the epidemiology of the disease. The frequency of unaffected, heterozygous carriers of the SMN1 mutations appears to be higher among Caucasian and Asian populations compared to the Black (Sub-Saharan African ancestry) population. However, carrier frequencies cannot directly be translated into incidence and prevalence, as very severe (death in utero) and very mild (symptom free in adults) phenotypes carrying bi-allelic SMN1 mutations exist, and their frequency is unknown. More robust epidemiological data on SMA covering larger populations based on accurate genetic diagnosis or newborn screening would be helpful to support planning of clinical studies, provision of care and therapies and evaluation of outcomes.Keywords
Funding Information
- Biogen
This publication has 114 references indexed in Scilit:
- Genetic testing of sperm donors for cystic fibrosis and spinal muscular atrophy: evaluation of clinical utilityEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Homozygous SMN2 deletion is a protective factor in the Swedish ALS populationEuropean Journal of Human Genetics, 2012
- Identification of bidirectional gene conversion between SMN1 and SMN2 by simultaneous analysis of SMN dosage and hybrid genes in a Chinese populationJournal of the Neurological Sciences, 2011
- Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimensEuropean Journal of Human Genetics, 2011
- A common spinal muscular atrophy deletion mutation is present on a single founder haplotype in the US HutteritesEuropean Journal of Human Genetics, 2011
- Carrier Screening for Spinal Muscular Atrophy (SMA) in 107,611 Pregnant Women during the Period 2005–2009: A Prospective Population-Based Cohort StudyPLOS ONE, 2011
- Molecular characterization of SMN copy number derived from carrier screening and from core families with SMA in a Chinese populationEuropean Journal of Human Genetics, 2010
- Differences in SMN1 allele frequencies among ethnic groups within North AmericaJournal of Medical Genetics, 2009
- Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophyBrain & Development, 2009
- Epidemiology of neuromuscular disorders in the under-20 population in Bologna province, ItalyNeuromuscular Disorders, 1992